Filing metadata

Accession number
0000950170-24-088675
Form type
Form 3
Filer
SAB Biotherapeutics, Inc.
CIK
CIK 1833214
Filed
Jul 31, 2024
Reporting period
Jul 26, 2024
Description
Initial ownership

Explore SEC Filings Hub